Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Operating Expenses (2020 - 2025)

BioAtla's Operating Expenses history spans 6 years, with the latest figure at $11.3 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 30.71% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $61.3 million, down 27.83%, while the annual FY2025 figure was $61.3 million, 27.83% down from the prior year.
  • Operating Expenses reached $11.3 million in Q4 2025 per BCAB's latest filing, down from $13.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $37.2 million in Q2 2023 to a low of $11.3 million in Q4 2025.
  • Average Operating Expenses over 5 years is $24.0 million, with a median of $24.0 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: surged 1469.03% in 2021, then plummeted 43.08% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $23.5 million in 2021, then grew by 21.59% to $28.6 million in 2022, then dropped by 0.08% to $28.5 million in 2023, then tumbled by 43.08% to $16.2 million in 2024, then plummeted by 30.71% to $11.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Operating Expenses are $11.3 million (Q4 2025), $13.8 million (Q3 2025), and $18.6 million (Q2 2025).